Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cells
dc.contributor.author | Avci, C. Birav | |
dc.contributor.author | Kayabasi, C. | |
dc.contributor.author | Susluer, S. Yilmaz | |
dc.contributor.author | Balci, T. | |
dc.contributor.author | Saydam, G. | |
dc.contributor.author | Baran, Y. | |
dc.contributor.author | Gunduz, C. | |
dc.date.accessioned | 2019-10-27T22:08:23Z | |
dc.date.available | 2019-10-27T22:08:23Z | |
dc.date.issued | 2013 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS | en_US |
dc.description.sponsorship | European Conf Clin Oncol, European Soc Therapeut Radiol & Oncol, European Soc Med Oncol, European Soc Surg Oncol, European Assoc Canc Res, European Oncol Nursing Soc, European Soc Paediat Oncol | en_US |
dc.identifier.endpage | S840 | en_US |
dc.identifier.issn | 0959-8049 | |
dc.identifier.issn | 1879-0852 | |
dc.identifier.startpage | S840 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/49171 | |
dc.identifier.volume | 49 | en_US |
dc.identifier.wos | WOS:000326843605259 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Sci Ltd | en_US |
dc.relation.ispartof | European Journal of Cancer | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cells | en_US |
dc.type | Conference Object | en_US |